Search research articles
Contact Us
Filters
Showing results (361-370 of 396) with videos related to
Page
of 40
Sort By:
The Journal of Clinical Endocrinology and Metabolism
|
April 5, 2022
Trends in Type 1 Diabetic Ketoacidosis During COVID-19 Surges at 7 US Centers: Highest Burden on non-Hispanic Black Patients
Andrew R Lavik, Osagie Ebekozien, Nudrat Noor, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
February 9, 2010
Functional neuroimaging of minocycline's effect in a patient with schizophrenia
Cristiano Chaves, Cristiane R de Marque, Lauro Wichert-Ana, et al.
Clinical Diabetes : a Publication of the American Diabetes Association
|
August 23, 2021
Multi-Clinic Quality Improvement Initiative Increases Continuous Glucose Monitoring Use Among Adolescents and Young Adults With Type 1 Diabetes
Priya Prahalad, Osagie Ebekozien, G Todd Alonso, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
December 17, 2020
Effects of the Soluble Guanylate Cyclase Stimulator Praliciguat in Diabetic Kidney Disease: A Randomized Placebo-Controlled Clinical Trial
John P Hanrahan, Ian H de Boer, George L Bakris, et al.
Veterinary Microbiology
|
September 17, 2013
Development and validation of an attenuated Mycoplasma hyopneumoniae aerosol vaccine
Zhi-Xin Feng, Yan-Na Wei, Gui-Lan Li, et al.
Medrxiv : the Preprint Server for Health Sciences
|
April 2, 2024
Distinct spatiotemporal atrophy patterns in corticobasal syndrome are associated with different underlying pathologies
W J Scotton, C Shand, E G Todd, et al.
Biorxiv : the Preprint Server for Biology
|
January 7, 2025
Neonatal systemic gene therapy restores cardiorespiratory function in a rat model of Pompe disease
David D Fuller, Sabhya Rana, Prajwal Thakre, et al.
Diabetologia
|
December 21, 2019
An exploratory, randomised, placebo-controlled, 14 day trial of the soluble guanylate cyclase stimulator praliciguat in participants with type 2 diabetes and hypertension
John P Hanrahan, Jelena P Seferovic, James D Wakefield, et al.
Veterinary Journal (London, England : 1997)
|
July 29, 2014
Use of serological and mucosal immune responses to Mycoplasma hyopneumoniae antigens P97R1, P46 and P36 in the diagnosis of infection
Zhi-Xin Feng, Yun Bai, Jing-Ting Yao, et al.
Brain Communications
|
March 12, 2025
Distinct spatiotemporal atrophy patterns in corticobasal syndrome are associated with different underlying pathologies
William J Scotton, Cameron Shand, Emily G Todd, et al.
Page
of 40
Search research articles
Search
Showing results (361-370 of 396) with videos related to
Sort By:
Page
of 40
The Journal of Clinical Endocrinology and Metabolism
|
April 5, 2022
Trends in Type 1 Diabetic Ketoacidosis During COVID-19 Surges at 7 US Centers: Highest Burden on non-Hispanic Black Patients
Andrew R Lavik, Osagie Ebekozien, Nudrat Noor, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
February 9, 2010
Functional neuroimaging of minocycline's effect in a patient with schizophrenia
Cristiano Chaves, Cristiane R de Marque, Lauro Wichert-Ana, et al.
Clinical Diabetes : a Publication of the American Diabetes Association
|
August 23, 2021
Multi-Clinic Quality Improvement Initiative Increases Continuous Glucose Monitoring Use Among Adolescents and Young Adults With Type 1 Diabetes
Priya Prahalad, Osagie Ebekozien, G Todd Alonso, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
December 17, 2020
Effects of the Soluble Guanylate Cyclase Stimulator Praliciguat in Diabetic Kidney Disease: A Randomized Placebo-Controlled Clinical Trial
John P Hanrahan, Ian H de Boer, George L Bakris, et al.
Veterinary Microbiology
|
September 17, 2013
Development and validation of an attenuated Mycoplasma hyopneumoniae aerosol vaccine
Zhi-Xin Feng, Yan-Na Wei, Gui-Lan Li, et al.
Medrxiv : the Preprint Server for Health Sciences
|
April 2, 2024
Distinct spatiotemporal atrophy patterns in corticobasal syndrome are associated with different underlying pathologies
W J Scotton, C Shand, E G Todd, et al.
Biorxiv : the Preprint Server for Biology
|
January 7, 2025
Neonatal systemic gene therapy restores cardiorespiratory function in a rat model of Pompe disease
David D Fuller, Sabhya Rana, Prajwal Thakre, et al.
Diabetologia
|
December 21, 2019
An exploratory, randomised, placebo-controlled, 14 day trial of the soluble guanylate cyclase stimulator praliciguat in participants with type 2 diabetes and hypertension
John P Hanrahan, Jelena P Seferovic, James D Wakefield, et al.
Veterinary Journal (London, England : 1997)
|
July 29, 2014
Use of serological and mucosal immune responses to Mycoplasma hyopneumoniae antigens P97R1, P46 and P36 in the diagnosis of infection
Zhi-Xin Feng, Yun Bai, Jing-Ting Yao, et al.
Brain Communications
|
March 12, 2025
Distinct spatiotemporal atrophy patterns in corticobasal syndrome are associated with different underlying pathologies
William J Scotton, Cameron Shand, Emily G Todd, et al.
Page
of 40